Lipid Emulsion Therapy in Local Anesthetic Toxicity

Lipid emulsion therapy has emerged over the past two decades as a life-saving intervention for local anaesthetic systemic toxicity (LAST). Intravenous administration of a triglyceride-rich emulsion creates an expanded intravascular lipid phase that sequesters lipophilic anaesthetic molecules away from cardiac and neural tissues. This “lipid sink” effect is complemented by direct cardiotonic actions, enhanced fatty acid delivery for mitochondrial energy production and modulatory influences on ion channels. Clinically, lipid emulsion is regarded as first-line rescue for cardiovascular collapse and refractory arrhythmias due to excessive local anaesthetic plasma concentrations. International guidelines now recommend prompt bolus infusion followed by sustained infusion in cases of last-resort cardiovascular instability. Despite widespread adoption, optimal dosing regimens, infusion duration and potential adverse effects remain under active investigation. Beyond reversal of LAST, this therapy is being explored for overdoses of other highly lipophilic drugs, emphasising its broad toxicological utility.

Research from Nature Portfolio

Recent studies have uncovered novel neuroprotective mechanisms by which lipid emulsion mitigates central nervous system injury induced by potent local anaesthetics. In neonatal rat hippocampal neurons exposed to bupivacaine, lipid emulsion restored cell viability by modulating the balance between brain-derived neurotrophic factor and its precursor. Specifically, emulsion treatment increased TrkB receptor signalling while simultaneously dampening proBDNF-p75NTR activation, resulting in reduced caspase-3 cleavage and apoptosis. These findings illuminate a receptor-mediated rescue pathway that extends beyond simple sequestration, suggesting that lipid emulsion may actively promote neuronal survival under toxic insult.

Lipid Emulsion Therapy in Local Anesthetic Toxicity publication trend

The graph below shows the total number of articles in lipid emulsion therapy in local anesthetic toxicity across all publications each year (not limited to Nature Index journals).

Technical terms

Lipid sink: The intravascular lipid phase created by infusion, which partitions and sequesters lipophilic drugs away from target tissues.

Local anaesthetic systemic toxicity (LAST): A severe syndrome of neurological and cardiovascular disturbances resulting from excessive plasma concentrations of local anaesthetics.

BDNF-TrkB/proBDNF-p75NTR pathway: A signalling cascade in which mature brain-derived neurotrophic factor activates the TrkB receptor to promote neuronal survival, while proBDNF binding to p75NTR triggers apoptotic pathways.

References

1. Lipid Emulsion to Treat Acute Poisonings: Mechanisms of Action, Indications, and Controversies. Pharmaceutics (2023).
2. BDNF-TrkB/proBDNF-p75NTR pathway regulation by lipid emulsion rescues bupivacaine-induced central neurotoxicity in rats. Scientific Reports (2023).
3. Biodetoxification Using Intravenous Lipid Emulsion, a Rescue Therapy in Life-Threatening Quetiapine and Venlafaxine Poisoning: A Case Report. Toxics (2023).
4. Mechanisms and Efficacy of Intravenous Lipid Emulsion Treatment for Systemic Toxicity From Local Anesthetics. Frontiers in Medicine (2021).